期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰腺癌的分子生物学研究进展 被引量：2

Advances of molecular biology in pancreatic carcinoma
暂未订购
导出
摘要 近年 ,与胰腺癌相关的新的癌基因和抑癌基因不断被克隆和发现 ,为胰腺癌的发病机制的探讨、诊断和治疗提供了许多新的靶点。基于此 ,笔者就胰腺癌的分子发生机制、基因诊断和基因治疗作一综述。
作者 东星 周卫东
机构地区 解放军第二O五医院普外科
出处 《中国普通外科杂志》 CAS CSCD 2004年第6期454-456,共3页 China Journal of General Surgery
关键词 胰腺肿瘤/遗传学 综述文献 分子生物学
分类号 R735.9 [医药卫生—肿瘤] R44 [医药卫生—诊断学]
  • 相关文献

参考文献22

  • 1Boring C ,Squires T,Tong T,et al.Cancer Statistics [ J ] .Cancer J Clin,1993,43(1) :7 -26.
  • 2Flanders TY,Foulkes WD.Pancreatic adenocarcinoma:epidemiology and genetics[ J].J Med Genet,1996,33(11) :889 -898.
  • 3Yanagisawa A,Ohtake K,Ohashi K,et al.Frequent C-ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation[ J].Cancer Res,1993,53(5) :953 -956.
  • 4Brigitte P,Sonke A,Ken B,et al.Analysis of K- ras mutation in pancreatic tissue after fine needle aspirates [ J ].Anticancer Res,1999,19(10) :2481 -2483.
  • 5Schwarte-Waldhoff I,Volpert OV,Bouck NP,et al.Snad4/DPC4-mediated tumor suppression through suppression of angiogenesis [ J ].Proc Natl Acad Sci USA,2000,97 (17) :9624 -9629.
  • 6Siard C,Kim S,Mirtosis C,et al.In testinal tumorigenesis in compound mutant mice of both DPC4 ( Smad4 ) and Apc genes[J].J Biol Chem,2000,275(7) :2063 -2072.
  • 7黄忠诚,杨竹林,李永国,钟德,王群伟,黄生福.胰腺癌组织s mad_4m RNA,TGF-β_1和TGF-βR_1的表达及意义[J].中国普通外科杂志,2002,11(10):609-611. 被引量：8
  • 8赵晓晏,尚瑞莲,夏时海,郭萍.原发性胰腺癌中p16基因突变及其蛋白表达的研究[J].重庆医学,2002,31(3):163-166. 被引量：8
  • 9Yamada T,Nakamori S,Ohzato H.Detection of K-ras gene mutation in plasma DNA of patients with pancreatic adenocarcinoma:correlation with clinicopathological features [ J ] .Clin cancer Res,1998,4(6) :1527-1532.
  • 10王文耀,胡先贵,曹贵松,唐岩,孙树汉,胡育新.胰腺癌患者外周血游离K-ras基因突变检测的临床意义[J].第二军医大学学报,2002,23(3):276-278. 被引量：3

二级参考文献22

  • 1[1]Tsutsumi M, Tsujiuchi T,Ishikawa O,et al.Increased telomerase activities in human pancreatic duct adenocarcinomas[J]. Jpn J Cancer Res,1997,88(10):971-976.
  • 2[2]Iwao T,Hiyama E,Yokoyama T,et al.Telomerase activity for the preoperative diagnosis of pancreatic cancer[J].J Natl Cancer Inst,1997,89(21):1621-1623.
  • 3[3]Hiyama E,Kodama T,Shinbara K, et al.Telomerase activity is detected in pancreatic cancer but not in benign tumors[J]. Cancer Res,1997,57(2):326-331.
  • 4[4]Myung SJ, Kim MH,Kim YS,et al. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation[J]. Gastrointest Endosc, 2000,51(6):708-713.
  • 5[5]Suehara N,Mizumoto K,Kusumoto M,et al.Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer[J].Am J Gastroenterol, 1998,93(10):1967-1971.
  • 6Bos J L.Ras oncogenes in human cancer:a review,1989.
  • 7Ochi K;Hasuoka H;Mizushima Y.A case of small pancreatic cancer diagnosed by serial follow-up studies promptly by a positive K-ras point mutation in pure pancreatic juice,1998.
  • 8Mulcahy H;Farthing MJ.Diagnosis of pancreatico-biliary malignancy:detection of gene mutations in plasma and stool[J],1999(Suppl 4).
  • 9Mulcaty HE;Lyautey J;Lederrey C.A prospective study of K-ras mutations in the plasma of pancreatic cancer patients[J],1998(02).
  • 10Theodor L;Melzer E;Sologov M.Detection of pancreatic carcinoma:diagnostic value of K-ras mutations in circulating DNA from serum[J],1999(10).

共引文献24

同被引文献19

  • 1魏海燕,陈立波,王春友.低氧诱导因子-1α mRNA在胰腺癌组织中的表达与胰腺癌生物学特征的关系[J].癌症,2005,24(2):184-188. 被引量：14
  • 2黄涛,高军,冯延平,常青,胡均,秦仁义,裘法祖.β1整合素反义寡核苷酸对人胰腺癌裸鼠皮下移植瘤的治疗作用[J].中国普通外科杂志,2005,14(11):809-812. 被引量：2
  • 3王宇令,刘源,张建勋,葛春林.Survivin在胰腺癌中的表达及其与胰腺癌增殖活性的关系[J].中国普通外科杂志,2005,14(11):817-819. 被引量：6
  • 4Moulder JE,Rockwell S.Tumor hypoxia:its impact on cancer therapy[J].Cancer Metast Rev,1987,5(4):313-341.
  • 5Xiang R,Mizutani N,Luo Y,et al.A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication[J].Cancer Res,2005,65(2):553-561.
  • 6Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95),Bax,caspases,and anticancer drugs[J].Cancer Res,1998,58(23):5315-5320.
  • 7Shibaji T,Nagao M,Ikeda N,et al.Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer[J].Anticancer Res,2003,23(6C):4721-4727.
  • 8Sarela AI,Verbeke CS,Ramsdale J,et al.Expression of survivin,a novel inhibitor of apoptosis and cell cycle regulatory protein,in pancreatic adenocarcinoma[J].Br J Cancer,2002,86(6):886-892.
  • 9Yasui W,Yokozaki H,Fujimoto J,et al.Genetic and epigenetic alterations in multistep carcinogenesis of the stomach[J].Gastroenterol,2000,35(12):111-115.
  • 10Kamb A,Gruis NA,Wearer-Feldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,264(5157):436-440.

引证文献2

二级引证文献13

中国普通外科杂志
2004年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部